Search
Powered By HealthLine
Health Tools
 PSA Test
 The Basics of the Prostate
 Prostate Q&A
 Basics of Erectile Dysfunction
 Tips For Men's Sexual Health
Featured Conditions
 Erectile Dysfunction
 Prostate
 Heart
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Risk of Death After ACS Different for Men and Women

Ivanhoe Broadcast News


Related Encyclopedia
 border=
Amenorrhea
Amniocentesis
Amniocentesis and CVS
Ankylosing Spondylitis
More...

Related Healthscout Videos
 border=
Baby Steps: Fertility Findings
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
Fighting Breast Cancer on Your Lunch Break
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Cialis
Detrol LA
Diflucan
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
'Freezing' Secondary Breast Cancer Tumors Shows Promise
More...

(Ivanhoe Newswire) -- Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS) such as heart attack or unstable angina, according to a new study.

Cardiovascular disease is the leading cause of death in both men and women, accounting for one-third of all deaths. Although several studies have shown an improvement of prognosis in women over time, overall outcomes remain worse for women compared with men, providing a strong rationale for focusing on the study of sex-based differences in the outcome of ACS.

Text Continues Below



Jeffrey S. Berger, M.D., M.S., of the New York University School of Medicine and colleagues evaluated the relationship between gender and 30-day mortality following ACS. They analyzed factors such as clinical classification at the time of ACS and the severity of angiographic disease. Patients for the study were pooled from a sample of 11 independent, international, randomized ACS clinical trials between 1993 and 2006.

Of the 136,247 patients in this analysis, 28 percent were women. There were 102,004 patients (26 percent women) with ST-segment elevation myocardial infarction (STEMI, a certain pattern on an electrocardiogram following a heart attack); 14,466 with non-STEMI (29 percent women); and 19,777 with unstable angina (40 percent women). Women were older and had a higher prevalence of hypertension, hyperlipidemia, diabetes and heart failure. Men were more likely to be smokers and had a higher prevalence of prior heart attack and prior coronary artery bypass graft surgery.

"Perhaps the most striking findings in our analyses relate to the examination of mortality according to type of ACS. We found a significant interaction between sex and type of ACS, such that 30-day mortality risk among women was modestly higher than men only for those patients presenting with STEMI. In patients with NSTEMI and unstable angina, women had a lower adjusted 30-day mortality risk than men. In fact, the strongest finding after full adjustment was lower risk among women with unstable angina," the authors write.

The researchers also found that women who underwent catheterization were more likely than men to have non-obstructive coronary artery disease and less likely to have multi-vessel disease. The relationship between gender and 30-day mortality was similar across the levels of angiographic disease severity.

"Sex-based differences exist in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences are markedly attenuated following adjustment for clinical differences and angiographic data, the researchers concluded. Understanding and considering these differences may lead to better risk stratification and treatment of all patients with ACS."

SOURCE: Journal of the American Medical Association (JAMA), August 26, 2009

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 8/28/2009

Related Links
 border=
From Healthscout's partner site on erectile dysfunction, ErectileDysfunctionConnection.com
SELF-TEST: Test your ability to achieve an erection
HOME REMEDY: Treat ED with herbs and supplements
DRUGS: Common drugs used to treat impotence





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire